Company registration number 16176687 (England and Wales)
INVAMED HOLDINGS LIMITED
FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 NOVEMBER 2025
PAGES FOR FILING WITH REGISTRAR
INVAMED HOLDINGS LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
INVAMED HOLDINGS LIMITED
BALANCE SHEET
AS AT
30 NOVEMBER 2025
30 November 2025
- 1 -
2026
Notes
£
£
Fixed assets
Investments
3
4,000,000
Current assets
Cash at bank and in hand
1,027
Creditors: amounts falling due within one year
5
(541,723)
Net current liabilities
(540,696)
Total assets less current liabilities
3,459,304
Creditors: amounts falling due after more than one year
6
(1,000,000)
Net assets
2,459,304
Capital and reserves
Called up share capital
1,027
Profit and loss reserves
2,458,277
Total equity
2,459,304
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
The financial statements were approved by the board of directors and authorised for issue on 8 October 2026 and are signed on its behalf by:
J W Pitt
Director
Company registration number 16176687 (England and Wales)
INVAMED HOLDINGS LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 30 NOVEMBER 2025
- 2 -
1
Accounting policies
Company information
Invamed Holdings Limited is a private company limited by shares incorporated in England and Wales. The registered office is Roma Medical Aids York Road, Bridgend Industrial Estate, Bridgend, Bridgend County Borough, Wales, CF31 3TB.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, [modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value]. The principal accounting policies adopted are set out below.
1.2
Going concern
Atruet the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
Turnover is measured at the fair value of the consideration received for the provision of services provided to subsidiary undertakings.
1.3
Fixed asset investments
Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
1.4
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.5
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
INVAMED HOLDINGS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 NOVEMBER 2025
- 3 -
2
Employees
The average monthly number of persons (including directors) employed by the company during the period was:
2026
Number
Total
4
3
Fixed asset investments
2026
£
Shares in group undertakings and participating interests
4,000,000
Movements in fixed asset investments
Shares in subsidiaries
£
Cost or valuation
At 10 January 2025
-
Additions
4,000,000
At 30 November 2025
4,000,000
Carrying amount
At 30 November 2025
4,000,000
4
Subsidiaries
Details of the company's subsidiaries at 30 November 2025 are as follows:
Name of undertaking
Registered office
Nature of business
Class of
% Held
shares held
Direct
Indirect
Invamed Group Limited
UK
Non-trading providing management services
Ordinary shares
100.00
-
Roma Medical Aids Limited
UK
Manufacture and sale of medical aids
Ordinary shares
0
100.00
Invamed Limited
UK
Dormant
Ordinary shares
0
100.00
The aggregate capital and reserves and the result for the year of the subsidiaries noted above was as follows:
Name of undertaking
Capital and Reserves
Profit/(Loss)
£
£
Invamed Group Limited
1,205,964
1,005,964
Roma Medical Aids Limited
5,028,290
Invamed Limited
1
INVAMED HOLDINGS LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE PERIOD ENDED 30 NOVEMBER 2025
- 4 -
5
Creditors: amounts falling due within one year
2026
£
Amounts owed to group undertakings
7,808
Other creditors
533,915
541,723
6
Creditors: amounts falling due after more than one year
2026
£
Other creditors
1,000,000
7
Audit report information
As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.
The auditor's report is unqualified and includes the following:
Opinion
In our opinion the financial statements:
give a true and fair view of the state of the company's affairs as at 30 November 2025 and of its profit for the period then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
Senior Statutory Auditor:
Catherine Ingram FCCA
Statutory Auditor:
Xeinadin Audit Limited
Date of audit report:
9 October 2026
8
Parent company
The ultimate controlling party is Mr JW Pitt by virtue of his shareholding in Invamed Holdings Limited.